A nitrobenzene derivative, MDL-860, was found to inhibit plaque formation, cytopathic effect, or both in 11 of 12 picornaviruses at concentrations which did not affect cell growth. The A search in The Dow Chemical Company laboratories for agents active against the picornaviruses led to the identification of the broadly active 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860). This agent exhibited high in vitro activity against the picornaviruses but not against viruses of other classes. This report is concerned with the spectrum of activity of MDL-860 and the results of some preliminary observations on its mechanism of action. The accompanying report (5) presents a more extensive evaluation of the antiviral spectrum of the compound.
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MATERIALS AND METHODS
Compound. MDL-860 was synthesized by L. Markley of The Dow Chemical Company, Midland, Mich. For easier dissolution in aqueous cell culture medium, the compound is first dissolved in 0.05 ml of dimethyl sulfoxide per 3 mg of MDL-860 and then diluted more than 100-fold in aqueous cell culture medium to produce a suspension of small particles.
Viruses (2) . HeLa cells were grown to confluent monolayers in 6-well culture plates. The growth medium was aspirated, the cells were inoculated at a multiplicity of infection of 1 to 10 with Cox A21 or RV 1-A, and the virus was allowed to adsorb for 1 h at 36°C. After the adsorption, each of three wells then received 2 ml of MEM containing 2% FCS and the indicated concentrations of MDL-860. As controls, and for determining the effect of MDL-860 on cellular RNA synthesis, another set of plates was prepared without virus inoculation. In the appropriate medium, 5 p.g of actinomycin D (ICN Pharmaceuticals, Inc.) per ml was added to block DNA-directed cellular RNA synthesis to allow determination of the non-blocked viral RNA- The viruses, at dilutions suitable for plaque determinations, were added to cell cultures with and without MDL-860 (10 pLg/ml). One set of plates was exposed to light within 5 to 10 min after addition of the virus. A duplicate set of plates was exposed to light 3 h after addition of the virus to destroy any virus retaining photosensitivity (coated). The cells then were washed three times to remove the compound, which could inhibit plaque formation by any virus not destroyed by light. Overlay medium was then added, and the plaques were allowed to develop. Details of the incu- bation and subsequent staining of the cells were described above.
RESULTS
Inhibition of viral plaque formation. The incorporation of MDL-860 into the agar overlay medium produced a significant reduction in Echo 12, RV Hank, and Cox B4 plaque formation at compound concentrations from 0.125 to 0.5 p.g/ ml ( Table 1) .
Inhibition of viral CPE. MDL-860 incorporated in the cell culture medium inhibited viral CPE for 11 of 12 picomaviruses at concentrations of 0.1 to 1.5 ,ug/ml. The compound did not inhibit the CPE of four non-picornaviruses tested (Table 2).
HeLa cell growth. Concentrations of MDL-860 up to and including 25 ,ug/ml of medium did not reduce the number or size of colonies which developed over an 8-day period of growth. (Table 3) . MDL-860 did not directly inactivate virus, suggesting an action in the infected cell. In studies of single-cycle viral replication which used a high multiplicity of infection, MDL-860 was found to inhibit viral RNA synthesis when it was added shortly after virus adsorption. Picornaviruses (Echo 12, Polio 2, and RV 1-A) made photosensitive with neutral red to measure viral uncoating were capable of losing photosensitivity during the first 3 h after infection of HeLa cells in the presence of antiviral concentrations of MDL-860. This was interpreted as evidence that viral uncoating was not affected (3, 4) . MDL-860 appeared to inhibit some early event in replication, after uncoating, which is required for synthesis of a majority of viral RNA.
